P418 Pharmacodynamic biomarkers demonstrate dose-dependent pharmacological activity of the IL-22Fc fusion protein UTR1147A in healthy volunteers in a phase 1a clinical trial

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2017-02, Vol.11 (suppl_1), p.S289-S289
Main Authors: Lekkerkerker, A., Harder, B., Kulkarni, P., Zhao, R., Choi, M., Noyes, A., Polihrom, A., Fillos, D., Rae, J., Danilenko, D., Stefanich, E., Herman, A., Lu, T.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1393-1c614d892f41480387d9a49134b4ccf70a992be5a2898cf4683fd27a6f1a289f3
cites
container_end_page S289
container_issue suppl_1
container_start_page S289
container_title Journal of Crohn's and colitis
container_volume 11
creator Lekkerkerker, A.
Harder, B.
Kulkarni, P.
Zhao, R.
Choi, M.
Noyes, A.
Polihrom, A.
Fillos, D.
Rae, J.
Danilenko, D.
Stefanich, E.
Herman, A.
Lu, T.
description
doi_str_mv 10.1093/ecco-jcc/jjx002.543
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ecco_jcc_jjx002_543</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_ecco_jcc_jjx002_543</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1393-1c614d892f41480387d9a49134b4ccf70a992be5a2898cf4683fd27a6f1a289f3</originalsourceid><addsrcrecordid>eNotkNFqwjAYhcPYYM7tCXaTF6gmTdomlyJzE4TJ0OsS02RN1yaSRFkfau-4Vr36DwfO98MHwCtGM4w4mSspXdJIOW-aX4TSWUbJHZhgVuQJpQW_v2SScE7zR_AUQoNQxrOCTcDflmIGt7XwnZCu6q3ojIQH4zrhf5QPsFKdsyF6ERWsXFBJpY7KVspGeLytWvdtpGihkNGcTeyh0zDWCq43SZquJNSnYJyFR--iMhbud18Y02IBh1wr0ca6h2fXnmxU48OhFSM6KIgFlK2xF3j0RrTP4EGLNqiX252C_eptt_xINp_v6-Vik0hMOEmwzDGtGE81xZQhwoqKC8oxoQcqpS6Q4Dw9qEykjDOpac6IrtJC5BqPlSZTQK5c6V0IXuny6M1gpC8xKkfj5Wi8HIyXV-PlYJz8Ay8cebI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>P418 Pharmacodynamic biomarkers demonstrate dose-dependent pharmacological activity of the IL-22Fc fusion protein UTR1147A in healthy volunteers in a phase 1a clinical trial</title><source>Oxford Journals Online</source><creator>Lekkerkerker, A. ; Harder, B. ; Kulkarni, P. ; Zhao, R. ; Choi, M. ; Noyes, A. ; Polihrom, A. ; Fillos, D. ; Rae, J. ; Danilenko, D. ; Stefanich, E. ; Herman, A. ; Lu, T.</creator><creatorcontrib>Lekkerkerker, A. ; Harder, B. ; Kulkarni, P. ; Zhao, R. ; Choi, M. ; Noyes, A. ; Polihrom, A. ; Fillos, D. ; Rae, J. ; Danilenko, D. ; Stefanich, E. ; Herman, A. ; Lu, T.</creatorcontrib><identifier>ISSN: 1873-9946</identifier><identifier>EISSN: 1876-4479</identifier><identifier>DOI: 10.1093/ecco-jcc/jjx002.543</identifier><language>eng</language><ispartof>Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S289-S289</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1393-1c614d892f41480387d9a49134b4ccf70a992be5a2898cf4683fd27a6f1a289f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Lekkerkerker, A.</creatorcontrib><creatorcontrib>Harder, B.</creatorcontrib><creatorcontrib>Kulkarni, P.</creatorcontrib><creatorcontrib>Zhao, R.</creatorcontrib><creatorcontrib>Choi, M.</creatorcontrib><creatorcontrib>Noyes, A.</creatorcontrib><creatorcontrib>Polihrom, A.</creatorcontrib><creatorcontrib>Fillos, D.</creatorcontrib><creatorcontrib>Rae, J.</creatorcontrib><creatorcontrib>Danilenko, D.</creatorcontrib><creatorcontrib>Stefanich, E.</creatorcontrib><creatorcontrib>Herman, A.</creatorcontrib><creatorcontrib>Lu, T.</creatorcontrib><title>P418 Pharmacodynamic biomarkers demonstrate dose-dependent pharmacological activity of the IL-22Fc fusion protein UTR1147A in healthy volunteers in a phase 1a clinical trial</title><title>Journal of Crohn's and colitis</title><issn>1873-9946</issn><issn>1876-4479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNotkNFqwjAYhcPYYM7tCXaTF6gmTdomlyJzE4TJ0OsS02RN1yaSRFkfau-4Vr36DwfO98MHwCtGM4w4mSspXdJIOW-aX4TSWUbJHZhgVuQJpQW_v2SScE7zR_AUQoNQxrOCTcDflmIGt7XwnZCu6q3ojIQH4zrhf5QPsFKdsyF6ERWsXFBJpY7KVspGeLytWvdtpGihkNGcTeyh0zDWCq43SZquJNSnYJyFR--iMhbud18Y02IBh1wr0ca6h2fXnmxU48OhFSM6KIgFlK2xF3j0RrTP4EGLNqiX252C_eptt_xINp_v6-Vik0hMOEmwzDGtGE81xZQhwoqKC8oxoQcqpS6Q4Dw9qEykjDOpac6IrtJC5BqPlSZTQK5c6V0IXuny6M1gpC8xKkfj5Wi8HIyXV-PlYJz8Ay8cebI</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Lekkerkerker, A.</creator><creator>Harder, B.</creator><creator>Kulkarni, P.</creator><creator>Zhao, R.</creator><creator>Choi, M.</creator><creator>Noyes, A.</creator><creator>Polihrom, A.</creator><creator>Fillos, D.</creator><creator>Rae, J.</creator><creator>Danilenko, D.</creator><creator>Stefanich, E.</creator><creator>Herman, A.</creator><creator>Lu, T.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20170201</creationdate><title>P418 Pharmacodynamic biomarkers demonstrate dose-dependent pharmacological activity of the IL-22Fc fusion protein UTR1147A in healthy volunteers in a phase 1a clinical trial</title><author>Lekkerkerker, A. ; Harder, B. ; Kulkarni, P. ; Zhao, R. ; Choi, M. ; Noyes, A. ; Polihrom, A. ; Fillos, D. ; Rae, J. ; Danilenko, D. ; Stefanich, E. ; Herman, A. ; Lu, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1393-1c614d892f41480387d9a49134b4ccf70a992be5a2898cf4683fd27a6f1a289f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lekkerkerker, A.</creatorcontrib><creatorcontrib>Harder, B.</creatorcontrib><creatorcontrib>Kulkarni, P.</creatorcontrib><creatorcontrib>Zhao, R.</creatorcontrib><creatorcontrib>Choi, M.</creatorcontrib><creatorcontrib>Noyes, A.</creatorcontrib><creatorcontrib>Polihrom, A.</creatorcontrib><creatorcontrib>Fillos, D.</creatorcontrib><creatorcontrib>Rae, J.</creatorcontrib><creatorcontrib>Danilenko, D.</creatorcontrib><creatorcontrib>Stefanich, E.</creatorcontrib><creatorcontrib>Herman, A.</creatorcontrib><creatorcontrib>Lu, T.</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of Crohn's and colitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lekkerkerker, A.</au><au>Harder, B.</au><au>Kulkarni, P.</au><au>Zhao, R.</au><au>Choi, M.</au><au>Noyes, A.</au><au>Polihrom, A.</au><au>Fillos, D.</au><au>Rae, J.</au><au>Danilenko, D.</au><au>Stefanich, E.</au><au>Herman, A.</au><au>Lu, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P418 Pharmacodynamic biomarkers demonstrate dose-dependent pharmacological activity of the IL-22Fc fusion protein UTR1147A in healthy volunteers in a phase 1a clinical trial</atitle><jtitle>Journal of Crohn's and colitis</jtitle><date>2017-02-01</date><risdate>2017</risdate><volume>11</volume><issue>suppl_1</issue><spage>S289</spage><epage>S289</epage><pages>S289-S289</pages><issn>1873-9946</issn><eissn>1876-4479</eissn><doi>10.1093/ecco-jcc/jjx002.543</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1873-9946
ispartof Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S289-S289
issn 1873-9946
1876-4479
language eng
recordid cdi_crossref_primary_10_1093_ecco_jcc_jjx002_543
source Oxford Journals Online
title P418 Pharmacodynamic biomarkers demonstrate dose-dependent pharmacological activity of the IL-22Fc fusion protein UTR1147A in healthy volunteers in a phase 1a clinical trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A06%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P418%20Pharmacodynamic%20biomarkers%20demonstrate%20dose-dependent%20pharmacological%20activity%20of%20the%20IL-22Fc%20fusion%20protein%20UTR1147A%20in%20healthy%20volunteers%20in%20a%20phase%201a%20clinical%20trial&rft.jtitle=Journal%20of%20Crohn's%20and%20colitis&rft.au=Lekkerkerker,%20A.&rft.date=2017-02-01&rft.volume=11&rft.issue=suppl_1&rft.spage=S289&rft.epage=S289&rft.pages=S289-S289&rft.issn=1873-9946&rft.eissn=1876-4479&rft_id=info:doi/10.1093/ecco-jcc/jjx002.543&rft_dat=%3Ccrossref%3E10_1093_ecco_jcc_jjx002_543%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1393-1c614d892f41480387d9a49134b4ccf70a992be5a2898cf4683fd27a6f1a289f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true